Cytochrome P-450 Enzyme Inhibitors
DBCAT000394Pharmacologic class
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. A DrugBank category of 810 drugs. 655 of them are approved.
- Also known as
- Cytochrome P 450 Dependent Monooxygenase Inhibitors · Cytochrome P 450 Enzyme Inhibitors · Cytochrome P 450 Inhibitors · Cytochrome P 450 Monooxygenase Inhibitors · Cytochrome P 450 Oxygenase Inhibitors
- Drugs
- (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
- 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
- 6-Deoxyerythronolide B
- Abametapir
- Abemaciclib
- Abiraterone
- Acalabrutinib
- Acebutolol
- Acetaminophen
- Acetazolamide
- Acetyl sulfisoxazole
- Acoramidis
- Adagrasib
- Ademetionine
- Agomelatine
- Albinterferon Alfa-2B
- Albuterol
- Aldesleukin
- Allicin
- Allopurinol
- Almonertinib
- Alosetron
- Alpelisib
- Alpibectir
- Aminophenazone
What you can answer from here — as of December 17, 2018
Which targets do Cytochrome P-450 Enzyme Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account